<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02288299</url>
  </required_header>
  <id_info>
    <org_study_id>2014-A01005-42</org_study_id>
    <nct_id>NCT02288299</nct_id>
  </id_info>
  <brief_title>Long-Term Effect of LIAM on Respiratory Performance in NIV Patients Suffering From Neuromuscular Disease</brief_title>
  <acronym>LIAM</acronym>
  <official_title>Long-Term Effect of LIAM (Lung Insufflation Assist Maneuver) on Respiratory Performance in Non-invasive Ventilated Patients Suffering From Neuromuscular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The long-term effect of LIAM (Lung Insufflation Assist Maneuver) on respiratory performance
      in home non-invasively ventilated (NIV) patients suffering from neuromuscular disease will be
      assessed in a prospective, randomized, cross over, open label study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In advanced neuromuscular disorders, respiratory complications represent the main cause of
      morbidity and mortality. Beside chronic respiratory insufficiency, necessitating a
      ventilatory support, mostly performed by non-invasive ventilation (NIV), cough is impaired
      due to the muscle weakness, and respiratory physiotherapy becomes an essential part of the
      management.

      Various techniques have been proposed to improve lung recruitment and cough in neuromuscular
      patients. The assisted techniques based on a positive pressure insufflation maneuver have
      shown an improvement in physiological variables on the short term, but there is to date no
      good-quality prospective study allowing to evaluate the long term efficacy of mechanical
      cough assistance devices in neuromuscular patients.

      We designed a randomized, cross over, open label study to assess the long-term effect of LIAM
      (Lung Insufflation Assist Maneuver) on respiratory performance in NIV patients suffering from
      neuromuscular disease.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the maximal assisted vital capacity (maximal insufflation capacity) between the begin of the treatment period and the 3-months follow up</measure>
    <time_frame>15 minutes</time_frame>
    <description>Change in the maximal assisted vital capacity (maximal insufflation capacity) between the begin of the treatment period and the 3-months follow up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>spontaneous vital capacity</measure>
    <time_frame>15 minutes</time_frame>
    <description>spontaneous vital capacity change at 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peak flow</measure>
    <time_frame>15 minutes</time_frame>
    <description>peak cough flow (spontaneous / assisted) change at 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>optoelectronic plethysmography</measure>
    <time_frame>1 hour</time_frame>
    <description>change at 3 months in the distribution in ventilation (assessed by optoelectronic plethysmography), spontaneous/assisted</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Neuromuscular Disease</condition>
  <arm_group>
    <arm_group_label>non invasive mechanical ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients suffering from neuromuscular disease with NIV indication and cough inefficiency</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>non invasive mechanical ventilation</intervention_name>
    <description>instrumental increase of inspiratory capacity and cough</description>
    <arm_group_label>non invasive mechanical ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  o neuromuscular disease ( progressive muscular dystrophy, for example; Duchenne
             muscular dystrophy, spinal muscular atrophy)

               -  age ≥ 18 years

               -  indication to NIV (ongoing ventilation or new patients)

               -  vital capacity ≤ 50% pred

               -  peak cough flow &lt; 270 l/min

               -  &quot;LIAM Responder&quot; = increased insufflation capacity (≥ + 50%) and Peak Cough Flow
                  (PCF ≥+ 50%) with LIAM

        Exclusion Criteria:

          -  o acute respiratory failure (respiratory acidosis)

               -  home treatment by instrumental cough assistance in the preceding 12 months

               -  ongoing medical treatment of the neuromuscular disease (for ex: corticosteroids
                  in Duchenne disease, enzyme therapy in Pompe disease)

               -  previous pneumothorax

               -  plan of legal protection

               -  pregnant or breastfeeding women

               -  failure to cooperate

               -  no affiliation to a social security scheme
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Orlikowski, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Orlikowski, MD, PhD</last_name>
    <phone>+33(0)147107777</phone>
    <email>david.orlikowski@rpc.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Frederic Lofaso, MD, PhD</last_name>
    <phone>+33(0)147107941</phone>
    <email>frederic.lofaso@rpc.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Home ventilation Unit , Raymond Poincaré hospital</name>
      <address>
        <city>Garches</city>
        <state>Paris Area</state>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Orlikowski, MD, PhD</last_name>
      <phone>33147107776</phone>
      <email>david.orlikowski@rpc.aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sandra Pottier, CRA</last_name>
      <phone>33 1 47 10 44 69</phone>
      <email>sandra.pottier@rpc.aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Helene Prigent, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Orlikowski, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frederic Lofaso, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Ogna, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2014</study_first_submitted>
  <study_first_submitted_qc>November 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2014</study_first_posted>
  <last_update_submitted>July 25, 2016</last_update_submitted>
  <last_update_submitted_qc>July 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Instrumental cough assistance</keyword>
  <keyword>positive pressure insufflation maneuver</keyword>
  <keyword>home mechanical ventilation</keyword>
  <keyword>prospective evaluation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

